NCT00133523View on ClinicalTrials.gov

FLU-VACS Comparative Study in Adults

PHASE4CompletedINTERVENTIONAL
Enrollment

2,349

Participants

Timeline

Start Date

October 31, 2004

Primary Completion Date

July 31, 2007

Study Completion Date

July 31, 2007

Conditions
Influenza
Interventions
BIOLOGICAL

Cold-adapted live attenuated influenza virus vaccine, trivalent

Live-attenuated influenza vaccine; single annual dose administered as an intranasal spray.

OTHER

Placebo

Physiological saline administered as an intramuscular injection.

BIOLOGICAL

Trivalent inactivated influenza vaccine

Inactivated influenza vaccine; single annual dose administered as an intramuscular injection..

BIOLOGICAL

Trivalent inactivated influenza vaccine

Inactivated influenza vaccine; single annual dose administered as an intramuscular injection.

OTHER

Placebo

Normal allantoic fluid administered annually as an internasal spray.

Trial Locations (6)

48103

Ann Arbor West, Ann Arbor

48150

Livonia East, Livonia

48197

Eastern Michigan University Health Services, Ypsilanti

48859

Central Michigan University Health Services, Mount Pleasant

49008

Western Michigan University Health Services, Kalamazoo

48109-2029

University of Michigan, Ann Arbor

All Listed Sponsors
lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT00133523 - FLU-VACS Comparative Study in Adults | Biotech Hunter | Biotech Hunter